Is serum alpha-fetoprotein useful for predicting recurrence and mortality specific to hepatocellular carcinoma after hepatectomy? A test based on propensity scores and competing risks analysis. - Wikidata - awgldk - TriplyDB

Is serum alpha-fetoprotein useful for predicting recurrence and mortality specific to hepatocellular carcinoma after hepatectomy? A test based on propensity scores and competing risks analysis.

Is serum alpha-fetoprotein useful for predicting recurrence and mortality specific to hepatocellular carcinoma after hepatectomy? A test based on propensity scores and competing risks analysis.

http://www.wikidata.org/entity/Q47695340

about

Prophylactic liver transplantation for high-risk recurrent hepatocellular carcinoma Risk Factors and Post-Resection Independent Predictive Score for the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma Model based on γ-glutamyltransferase and alkaline phosphatase for hepatocellular carcinoma prognosis.Elevated CA19-9 Is Associated With Increased Mortality In A Prospective Cohort Of Hepatocellular Carcinoma Patients.Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization.Identification of serum monocyte chemoattractant protein-1 and prolactin as potential tumor markers in hepatocellular carcinoma.Using serum α-fetoprotein for prognostic prediction in patients with hepatocellular carcinoma: what is the most optimal cutoff?Sensitive electrochemical immunosensor based on three-dimensional nanostructure gold electrode.Importance of SALL4 in the development and prognosis of hepatocellular carcinoma.Expression of GOLM1 correlates with prognosis in human hepatocellular carcinoma.Resection and transplantation for hepatocellular carcinoma: factors influencing surgical options.Vascular adhesion protein-1 is elevated in primary sclerosing cholangitis, is predictive of clinical outcome and facilitates recruitment of gut-tropic lymphocytes to liver in a substrate-dependent manner.Preoperative serum α-fetoprotein and prognosis after hepatectomy for hepatocellular carcinoma.Double primary hepatic cancer (hepatocellular carcinoma and intrahepatic cholangiocarcinoma) in a single patient: A case report.Assessing prognostic significance of preoperative alpha-fetoprotein in hepatitis B-associated hepatocellular carcinoma: normal is not the new normal.Persistent elevated C-reactive protein after treatment is an independent marker of a poor prognosis in patients with hepatocellular carcinoma.NLRC and NLRX gene family mRNA expression and prognostic value in hepatocellular carcinoma.The prognostic value of CYP2C subfamily genes in hepatocellular carcinoma.Prognostic factors in patients with HBV-related hepatocellular carcinoma following hepatic resection.Prognostic role of alpha-fetoprotein response after hepatocellular carcinoma resection.

P2860

Q28073769-EC5A585E-98CD-4915-A38A-B5D6B201FFA4 Q28550305-FD7608C3-B8BD-42BA-AE05-4FE65E15A3CD Q34067936-B23161BC-8CA2-41CE-A386-0A01719330F2 Q34667817-2634B3EB-AFA5-4923-A137-3498FFA47081 Q34847211-A8E95231-E97B-40BD-B61C-D1614167F2A0 Q34851700-8414D32E-F5F8-46D8-AD80-750DA332215E Q35148136-4AD819BB-27D9-4EA5-8F81-297DF10A9D42 Q35212806-2DDBE6D5-BF59-49A6-ADEE-85A2E4F24063 Q36650831-6AAFF376-E718-4B5C-A46A-D1474EA26DCA Q38120426-4BEDFA20-12A0-4BEE-95FD-49603F30674B Q38206274-196BFE30-96DA-45C6-A8BD-8CFE060A83C3 Q39534358-67C5B104-1924-48EC-A18E-68DA5122C710 Q40842666-C580D77C-21DD-46C5-9959-0239DA83C6C4 Q40914145-F21E902B-61EE-42E7-92A6-C17039A1FA4F Q42255569-05E41E09-C90D-48C7-B5C0-64BB5317059A Q46679276-C61AAA97-C6F6-4983-9832-7022DE38C896 Q47146232-46A615EF-28DF-4C86-98C6-7B61A51E9057 Q52685824-14303FDE-F683-4178-ABBB-853E9EE23EB1 Q55234213-05F9F6DC-94A3-478F-84CD-D4C1407D0D4E Q55505675-DDEF80EF-3A04-48A8-9955-CA596279B9A6

P2860

Is serum alpha-fetoprotein useful for predicting recurrence and mortality specific to hepatocellular carcinoma after hepatectomy? A test based on propensity scores and competing risks analysis.

http://www.wikidata.org/entity/Q47695340

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Is serum alpha-fetoprotein use ...... and competing risks analysis.

@en

Is serum alpha-fetoprotein use ...... and competing risks analysis.

@nl

type

label

Is serum alpha-fetoprotein use ...... and competing risks analysis.

@en

Is serum alpha-fetoprotein use ...... and competing risks analysis.

@nl

prefLabel

Is serum alpha-fetoprotein use ...... and competing risks analysis.

@en

Is serum alpha-fetoprotein use ...... and competing risks analysis.

@nl

P1433

Q47695340-C0A34ACC-CC0E-49A7-BA86-79154283D619

P1476

Q47695340-25D81438-368E-4E0C-9127-E9FF3C2B8E83

P2093

Q47695340-1E6D96D2-54DA-40FE-9306-8E81332B62CA

Q47695340-262537CA-F016-4820-B8EF-393F43BBCE11

Q47695340-3F7CF337-6329-4355-84EA-7B6F7411F50F

Q47695340-7A3EE966-FF80-4C5E-9528-78EAD93EDAEA

Q47695340-7D647670-D291-4736-BAEA-62EB08A06189

Q47695340-8C08C83A-2D44-43DF-9B66-20B38ACBBBDF

Q47695340-C8D41E52-13FD-46D3-9915-EEDE92A82792

Q47695340-F0707F0A-396F-409C-A506-FE99ABF4CFAC

Q47695340-FDA93FB2-01A0-4DA3-859E-824EAA6337F1

P2860

Q47695340-004CC05E-0C78-4348-BB0E-8C0ACDB54F97

Q47695340-133F4AE8-14C6-4C0C-9657-CAD307CDEDD4

Q47695340-1701D4A3-7275-4582-A514-C13526205078

Q47695340-175770DE-56E0-4F19-98F5-A131B92A5B4F

Q47695340-28390B01-A9E1-4410-9F8F-D07F4E1F4E75

Q47695340-2F55DB81-7D53-437A-A843-591C0A604EFF

Q47695340-3770E464-1691-462B-B023-322AF6BE9A93

Q47695340-3F2F7174-D9C7-43DE-9EED-FAB8ECB01249

Q47695340-6C85DA1C-E9CB-4C16-A816-87FF8F4AF021

Q47695340-708C31DE-CE2D-486A-8226-DBC89CBE9698

P2888

Q47695340-FBC1EAD6-11DD-4906-AF3D-E4D0C26AAF68

P304

Q47695340-FEC5A931-19AD-47C1-8590-95E9B9B1FB59

P31

Q47695340-DCAFBA13-0310-4DB5-A800-9B18E43B3226

P356

Q47695340-17B49B5F-3724-458F-A51C-FFDD9ECCD014

P433

Q47695340-A7C8EAC7-BD39-4CE9-A94A-C90F066B99CB

P478

Q47695340-D45B6B9F-A379-47C8-A511-2BC19A0932C6

P50

Q47695340-4C1C4C29-0379-41A6-9ED5-9BD3B95D3B1E

P577

Q47695340-CB62BDFF-DDFE-494A-9846-73FFC85A8749

P5875

Q47695340-B15E0AA7-5347-4569-9CE2-79CF2B1AA3D2

P6179

Q47695340-1D642F21-291E-4C3A-8383-826564AA5407

P698

Q47695340-32581CF9-0B54-44E4-B152-CAFAB18AC0B1

P921

Q47695340-1E05B04F-4A8B-4B35-86BF-7563366C9503

P356

S10434-012-2416-1

P1433

Annals of Surgical Oncology

P1476

Is serum alpha-fetoprotein use ...... s and competing risks analysis

@en

P2093

Da-Lim Yoon

http://www.w3.org/2001/XMLSchema#string

Han Chu Lee

http://www.w3.org/2001/XMLSchema#string

Kang Mo Kim

http://www.w3.org/2001/XMLSchema#string

Seungbong Han

http://www.w3.org/2001/XMLSchema#string

Sung-Gyu Lee

http://www.w3.org/2001/XMLSchema#string

Young-Hwa Chung

http://www.w3.org/2001/XMLSchema#string

Young-Joo Lee

http://www.w3.org/2001/XMLSchema#string

Young-Suk Lim

http://www.w3.org/2001/XMLSchema#string

Yung Sang Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hepatocellular carcinoma: An update

Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients

Biology of hepatocellular carcinoma

Marginal structural models and causal inference in epidemiology

Competing risk regression models for epidemiologic data.

Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma.

The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma.

Mean alpha-fetoprotein values of 1,333 males over 15 years by age groups.

A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire.

Clinical characteristics and prognosis of hepatocellular carcinoma: analysis based on serum alpha-fetoprotein levels.

P2888

s10434-012-2416-1

P304

3687-3696

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-012-2416-1

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225073689

http://www.w3.org/2001/XMLSchema#string

P6179

1019372341

http://www.w3.org/2001/XMLSchema#string

P698

22644512

http://www.w3.org/2001/XMLSchema#string

P921